CD8A and neoplasm: Enrichment analysis revealed that low-scoring patients exhibit an activated tumor immune microenvironment, with upregulated pathways in interferon-γ and IL-2/STAT5, which can activate immune cells such as CD8 + T cells and natural killer cells, suggesting mechanistic links to ICI sensitivity.